Wafaa El‐Sadr

28.8k total citations · 9 hit papers
364 papers, 19.8k citations indexed

About

Wafaa El‐Sadr is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Wafaa El‐Sadr has authored 364 papers receiving a total of 19.8k indexed citations (citations by other indexed papers that have themselves been cited), including 286 papers in Infectious Diseases, 161 papers in Epidemiology and 80 papers in Emergency Medicine. Recurrent topics in Wafaa El‐Sadr's work include HIV/AIDS Research and Interventions (205 papers), HIV, Drug Use, Sexual Risk (101 papers) and HIV-related health complications and treatments (79 papers). Wafaa El‐Sadr is often cited by papers focused on HIV/AIDS Research and Interventions (205 papers), HIV, Drug Use, Sexual Risk (101 papers) and HIV-related health complications and treatments (79 papers). Wafaa El‐Sadr collaborates with scholars based in United States, United Kingdom and Switzerland. Wafaa El‐Sadr's co-authors include Caroline Sabin, Peter Reiss, Antonella d’Arminio Monforte, Rainer Weber, Nina Friis‐Møller, Andrew Phillips, Jens Lundgren, Ole Kirk, Matthew Law and Miriam Rabkin and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Wafaa El‐Sadr

356 papers receiving 19.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD4+ Count–Guided Interruption of Antiretroviral Treatment

2006 1.6k citations Wafaa El‐Sadr New England Journal of Medicine profile →
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction

2003 1.3k citations Wafaa El‐Sadr, Caroline Sabin New England Journal of Medicine profile →
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

2003 802 citations Nina Friis‐Møller, Rainer Weber et al. AIDS profile →
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

2014 689 citations Lene Ryom, Rainer Weber et al. profile →
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

2008 675 citations Caroline Sabin, Signe Westring Worm et al. profile →
Microfluidics-based diagnostics of infectious diseases in the developing world

2011 589 citations Ruben Sahabo, Jessica Justman et al. profile →
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

2009 481 citations Signe Westring Worm, Caroline Sabin et al. profile →
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

2010 478 citations Wafaa El‐Sadr et al. New England Journal of Medicine profile →
Achieving the 95 95 95 targets for all: A pathway to ending AIDS

2022 198 citations Wafaa El‐Sadr et al. profile →

Peers

Countries citing papers authored by Wafaa El‐Sadr

Since Specialization

Citations

This map shows the geographic impact of Wafaa El‐Sadr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafaa El‐Sadr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafaa El‐Sadr more than expected).

Fields of papers citing papers by Wafaa El‐Sadr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wafaa El‐Sadr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafaa El‐Sadr. The network helps show where Wafaa El‐Sadr may publish in the future.

Co-authorship network of co-authors of Wafaa El‐Sadr

This figure shows the co-authorship network connecting the top 25 collaborators of Wafaa El‐Sadr. A scholar is included among the top collaborators of Wafaa El‐Sadr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wafaa El‐Sadr. Wafaa El‐Sadr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy 2021 ·Annals of Internal Medicine ·Frédérique Chammartin, Sara Lodi, Roger Logan, Lene Ryom, Amanda Mocroft, Ole Kirk, Antonella d’Arminio Monforte, Peter Reiss, Andrew Phillips, Wafaa El‐Sadr, Camilla Ingrid Hatleberg, Christian Pradier, Fabrice Bonnet, Matthew Law, Christoph Stephan, Caroline Sabin, Jens Lundgren, Heiner C. Bucher	16
2	Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan 2019 ·Harm Reduction Journal ·(unknown), Padmaja Patnaik, Wafaa El‐Sadr	19
3	Persons living with HIV with advanced HIV disease: need for novel care models 2018 ·Journal of the International AIDS Society ·Chloe A. Teasdale, Katharine A. Yuengling, Peter Preko, (unknown), Felix Ndagije, Miriam Rabkin, Elaine J. Abrams, Wafaa El‐Sadr	14
4	A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders 2018 ·Journal of the International AIDS Society ·Peter Ehrenkranz, (unknown), Wafaa El‐Sadr, Ade Fakoya, Nathan Ford, Anna Grimsrud, Kate Lockwood Harris, (unknown), Daniel Low‐Beer, Sadhna Patel, Miriam Rabkin, William Reidy, (unknown), George K. Siberry, (unknown), Isaac Zulu, Irum Zaidi	14
5	A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial 2017 ·PLoS Medicine ·Richard Hayes, Sian Floyd, Ab Schaap, Kwame Shanaube, Peter Bock, Kalpana Sabapathy, Sam Griffith, Deborah Donnell, Estelle Piwowar‐Manning, Wafaa El‐Sadr, Nulda Beyers, Helen Ayles, Sarah Fidler, (unknown)	88
6	Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial 2017 ·PLoS Medicine ·Margaret L. McNairy, Matthew R. Lamb, (unknown), Harriet Nuwagaba‐Biribonwoha, Sean Burke, Sikhathele Mazibuko, Velephi Okello, Peter Ehrenkranz, Ruben Sahabo, Wafaa El‐Sadr	57
7	Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators 2017 ·Drug and Alcohol Dependence ·(unknown), Wafaa El‐Sadr	20
8	Pregnant and breastfeeding women: A priority population for HIV viral load monitoring 2017 ·PLoS Medicine ·Landon Myer, Shaffiq Essajee, Laura N. Broyles, D. Heather Watts, Maia Lesosky, Wafaa El‐Sadr, Elaine J. Abrams	53
9	Mother and child both matter 2015 ·Current Opinion in HIV and AIDS ·Margaret L. McNairy, Chloe A. Teasdale, Wafaa El‐Sadr, Vidya Mave, Elaine J. Abrams	23
10	Predicting the short‐term risk of diabetes in HIV‐positive patients: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study 2012 ·Journal of the International AIDS Society ·Kathy Petoumenos, Signe Westring Worm, Éric Fontas, Rainer Weber, Stéphane De Wit, Mathias Bruyand, Peter Reiss, Wafaa El‐Sadr, Antonella d’Arminio Monforte, Nina Friis‐Møller, Jens Lundgren, Matthew Law, (unknown)	53
11	Challenges of a Hidden Epidemic: HIV Prevention Among Women in the United States 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Sally Hodder, Jessica Justman, Danielle F. Haley, Adaora A. Adimora, Catherine Ingram Fogel, Carol E. Golin, Ann O’Leary, Lydia Soto-Torres, Gina M. Wingood, Wafaa El‐Sadr	75
12	High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome 2010 ·AIDS ·Signe Westring Worm, Nina Friis‐Møller, Mathias Bruyand, Antonella d’Arminio Monforte, Martin Rickenbach, Peter Reiss, Wafaa El‐Sadr, Andrew Phillips, Jens Lundgren, Caroline Sabin	67
13	Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study 2010 ·European Journal of Cardiovascular Prevention & Rehabilitation ·Nina Friis‐Møller, Rodolphe Thiébaut, Peter Reiss, Rainer Weber, Antonella d’Arminio Monforte, Stéphane De Wit, Wafaa El‐Sadr, Éric Fontas, Signe Westring Worm, Ole Kirk, Andrew Phillips, Caroline Sabin, Jens Lundgren, Matthew Law, (unknown)	283
14	Effects of HIV Infection on Body Composition Changes Among Men of Different Racial/Ethnic Origins 2007 ·HIV Clinical Trials ·Fehmida Visnegarwala, (unknown), Vaughn Barry, Cynthia L. Gibert, Ying Xiang, Jack Wang, Donald P. Kotler, (unknown), Wafaa El‐Sadr, (unknown)	8
15	Tuberculosis in Rwanda: challenges to reaching the targets 2007 ·Europe PMC (PubMed Central) ·Michel Gasana, (unknown), (unknown), Jules Mugabo, Simon Tsiouris, (unknown), Alyssa Finlay, Jessica Justman, Ruben Sahabo, Wafaa El‐Sadr	3
16	CD4+ Count–Guided Interruption of Antiretroviral Treatment breakdown → 2006 ·New England Journal of Medicine ·Wafaa El‐Sadr	1649
17	A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients 1999 ·David L. Cohn, Evelyn J. Fisher, (unknown), James S. Hodges, (unknown), Carroll Child, (unknown), Cynthia L. Gibert, Wafaa El‐Sadr, Richard Hafner, Joyce A. Korvick, Mary E. Ropka, Leonid Heifets, (unknown), Donna J. Munroe, C. Robert Horsburgh	1
18	A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: Excess mortality associated with high-dose clarithromycin 1999 ·David L. Cohn, Evelyn J. Fisher, (unknown), James S. Hodges, (unknown), Carroll Child, (unknown), Cynthia L. Gibert, Wafaa El‐Sadr, Richard Hafner, Joyce A. Korvick, Mary E. Ropka, Leonid Heifets, (unknown), Donna J. Munroe, C. Robert Horsburgh	1
19	Safer sex strategies for women: The hierarchical model in methadone treatment clinics 1999 ·Journal of Urban Health ·Zena Stein, (unknown), Wafaa El‐Sadr, Cheryl Healton, Sharon Mannheimer, Peter Messeri, (unknown), Nancy Van Devanter, (unknown), (unknown)	18
20	HIGH-DOSE CORTICOSTEROIDS AS ADJUNCT THERAPY IN SEVERE PNEUMOCYSTIS CARINII PNEUMONIA 1986 ·PubMed ·Wafaa El‐Sadr, Gurdip S. Sidhu, Gigi R. Diamond, Abigail Zuger, Daniel S. Berman, Michael S. Simberkoff, James J. Rahal	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact